Journal of the Peripheral Nervous System

Article	Citations
	66
	49
Abstracts	38
	31
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	27
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	26
PNS Abstracts 2023	23
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	21
	19
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	19
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	18
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	17
Ofatumumab for treating autoimmune nodopathy	16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	16
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	16
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	15
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	15
Issue Information	14
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	14
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	13
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	12

Issue Information	12
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	11
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	11
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	11
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	10
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	10
Issue Information	10
Peter James Dyck: In Memoriam	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	9
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	9
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	9
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	9
Issue Information	9
	8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	8
	8
Issue Information	8
Issue Information	8
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	8
Issue Information	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
The autoimmune vulnerability of the node of Ranvier	6
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	6
ABSTRACT	6
	6
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	5
	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
Issue Information	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4

The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	4
Issue Information	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
Anxiety and depression in small fiber neuropathy	4
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis	3
A Case of Retinopathy–Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Varian	3
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome	3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies	3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury	3
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	3
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations	3
Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure	3
Issue Information	3
Issue Information	3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	3
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS	3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	3
Abstract	3
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	3
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders	3
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus	3
	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children	3
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	3
	3
	3
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report	2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome	2
Identification of cellular and noncellular components of mature intact human peripheral nerve	2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit	2
Unusual upper limb features in SORD neuropathy	2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla	2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement	2
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity	2
Issue Information	2
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity	2
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease	2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System	2
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes	2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients	2
Leptospirosis‐induced acute acquired inflammatory neuropathy	2
Correction to “The Correlation Between Functional and Morphometric Small Fiber Assessment in Mixed Etiology Polyneuropathy”	2
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome	2
	2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy	2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1	2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review	2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy	2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?	2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation	2
Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease	2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa	2
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report	1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy	1
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases	1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”	1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study	1
	1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)	1
Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape	1
Laura Feltri: In memoriam	1
Pseudodominant Inheritance of Biallelic RFC1 Expansions—Revisiting the 3p22‐p24 HSN1B Locus	1
Long‐Term Functional Outcomes in Immunoglobulin‐Treated Multifocal Motor Neuropathy Evaluated Through the MMN ‐Rasch‐Built Overall Disability Scale	1
ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome	1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy	1
Intrathecal Antibody Synthesis in Autoimmune Nodopathy	1
Motor Neuropathy in a Patient With Mitochondrial Disease and a Novel TTC19 Variant: An Underrecognized Phenotypic Feature	1

Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review	1
	1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy	1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response	1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges	1
Issue Information	1
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study	1
Issue Information	1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A1	1
Sural nerve biopsy utility by masked assessment of individual histologic preparations	1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	1
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course	1
Issue Information	1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A	1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy	1
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A	1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies	1
Issue Information	1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome	1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset	1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing	1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?	1
Serum neurofilament light chain measurements following nerve trauma	1
Issue Information	1
Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System	1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome	1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents	1
Abstract	1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy	1